Ossifying fibromyxoid tumor of the oral cavity: rare case report and long-term follow-up by Pérez-de-Oliveira, Maria Eduarda et al.
Copyright: © 2020 The Authors. This is an Open Access article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
1 Universidade Estadual de Campinas (UNICAMP), Faculdade de Odontologia de Piracicaba, Departamento de Diagnóstico Oral, Área de 
Semiologia e Patologia Oral, Piracicaba, SP, Brasil
2 University of Pretoria, School of Dentistry, Department of Oral Pathology and Oral Biology, Pretoria, South Africa
 Ossifying fibromyxoid tumor of the oral cavity: rare case report and 
long-term follow-up
Maria Eduarda Pérez-de-Oliveira1 , Thayná Melo de Lima Morais1, , 
Márcio Ajudarte Lopes1 , Oslei Paes de Almeida1 , Willie F. P. van Heerden2 , 
Pablo Agustin Vargas1,2 
How to cite: Pérez-de-Oliveira ME, Morais TML, Lopes MA, Almeida OP, van Heerden WFP, Vargas PA. Ossifying 
fibromyxoid tumor of the oral cavity: rare case report and long-term follow-up. Autops Case Rep [Internet]. 2021; 11: 
e2020216. https://doi.org/10.4322/acr.2020.216
Clinical Case Report and Review
ABSTRACT
Ossifying fibromyxoid tumor (OFMT) is a rare mesenchymal soft tissue benign neoplasm with an uncertain line of 
differentiation, which arises most frequently in extremities. The head and neck region involvement is uncommon, with 
only ten intraoral cases published in the English-language literature. One additional case of OFMT is reported here, 
including a literature review of intraoral reported cases. A 45-year-old female patient presented a painless nodule 
involving the buccal mucosa of approximately two years duration, measuring nearly 1.3 cm in maximum diameter. The 
main histopathological features include ovoid to round cells embedded in a fibromyxoid matrix with a perpheral shell of 
lamellar bone. Immunohistochemically, the tumor showed immunoreactivity for vimentin and S100. No recurrence has 
been detected after 7 years of follow-up. 
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INTRODUCTION
Ossifying fibromyxoid tumor (OFMT) is a rare 
mesenchymal soft tissue benign neoplasm with an 
uncertain line of differentiation and intermediate 
biologic behavior, which arises most frequently within 
the subcutaneous tissue of extremities, followed by 
the trunk. The head and neck region is less frequently 
involved, comprising about 10 to 15% of OFMTs. 
The tumor occurs more commonly in men than 
women, presenting as a small, asymptomatic mass with 
slow growth, mainly in middle-aged adults.1-3 Intraoral 
presentation is very rare, with only ten cases reported 
in the English-language literature.
OFMT was first reported by Enzinger et al.4 in 1989 and 
is characterized by bland ovoid to round cells embedded 
in a fibromyxoid, chondroid, or hyaline matrix with 
a peripheral shell of lamellar bone. It has been 
recognized that a small subset of OFMTs exhibit 
atypical features such as high cellularity and mitotic 
activity with aggressive clinical behavior. These have 
been considered as malignant OFMT.5 Additionally, 
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OFMTs have morphologic and immunohistochemical 
features that overlap with several soft tissue tumors, 
making recognition of this entity relevant. This 
report aims to describe the histopathological and 
immunohistochemical features of a rare case of OFMT 
involving the buccal mucosa with a review of the 
English-language literature to characterize this lesion 
better.
CASE REPORT
A 45-year-old female patient presented with 
a painless nodule in the anterior region of buccal 
mucosa of approximately two years duration. Intraoral 
examination revealed a submucosal, smooth-surfaced, 
well-circumscribed, and normochromic nodule, 
which measured nearly 1.3 cm in maximum diameter 
(Figure 1).
The patient’s medical history was unremarkable. 
The differential clinical diagnoses were fibrous 
hyperplasia and pleomorphic adenoma. Based on these 
hypotheses, the lesion was excised, and the surgical 
specimen sent for histopathological analysis.
Microscopically, hematoxylin-eosin stain sections 
showed a well-circumscribed tumor with a complete 
fibrous capsule that extended fibrous septae into 
the tumor, separating the hypercellular areas from 
moderate and hypocellular areas. Bone deposition, 
with hematopoietic marrow formation, was observed 
within the fibrous capsule at the periphery of 
the tumor. Tumor cellularity varied from low and 
moderate to high. The cells were arranged in sheets, 
ranging from small round to oval to fusiform in 
shape, containing bland oval to round nuclei with 
fine chromatin and indistinct cytoplasmic borders. 
The hypercellular areas showed nuclear overlapping 
and less intercellular matrix, while the hypocellular 
areas presented abundant fibromyxoid stroma. 
Hyaline areas, resembling chondroid or osteoid 
material, were found in the center of the lesion. 
Additionally, the stroma presented fine vessels, 
mainly in the myxoid and hyaline areas. Few mitoses 
were also found, particularly in hypercellular areas 
(Figure 2 and Figure 3).
The tumor cells showed immunoreactivity for 
vimentin and S100 protein, and negativity for pan-
cytokeratin (AE1/AE3), GFAP, CD34, calponin, and 
P63. INI-1 nuclear expression was conserved in all 
tumor cells (Table 1, Figure 4, and Figure 5). Based 
on the histopathological and immunohistochemical 
features, a final diagnosis of intraoral OFMT was 
made. No recurrence has been detected after 7 years 
of follow-up.
DISCUSSION
OFMT is a rare neoplasm of soft tissues that 
arises more commonly in the extremities and trunk. 
The head and neck region is involved in only 10 to 15% 
of the cases. Clinically, most OFMT presents as a 
Figure 1. Clinical features of the intraoral OFMT. A – A painless nodule in the anterior region of buccal mucosa 
with approximately 2 years of duration; B – A well-circumscribed submucosal nodule with a smooth surface and 
normochromic in the anterior region of buccal mucosa measuring 1.3 cm in maximum diameter.
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Figure 2. Photomicrographs of the intraoral ossifying fibromyxoid tumor. A – A well-circumscribed tumor with 
a complete fibrous capsule that extended fibrous septa, separating the hypercellular area from other areas (H&E, 
1.44x); B – Peripheral shell of lamellar bone within the fibrous capsule (H&E, 5x); C – The cells range from small 
round to oval to fusiform shapes, with bland nuclei with fine chromatin and indistinct cytoplasm borders. The 
hypercellular area exhibited less intercellular matrix, often showing nuclear overlapping (H&E, 20x); D – Intermediate 
cellularity (H&E, 20x).
Figure 3. Photomicrographs of the intraoral ossifying fibromyxoid tumor. A – Hypocellular area with abundant 
fibromyxoid matrix (H&E, 20x); B – Hyaline material in the center of the lesion resembling chondroid or osteoid 
material (H&E, 10x).
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Figure 4. Immunohistochemical reactions of the intraoral ossifying fibromyxoid tumor. A – Vimentin showed 
cytoplasmic positivity in all tumor cells (20x); B – Intact nuclear expression of INI-1 in all tumor cells (20x); C – S100 
exhibit nuclear positivity in the tumor cells; D – mainly in fibromyxoid and hyaline areas (20x).
Table 1. Immunohistochemical profile of the present intraoral ossifying fibromyxoid tumor
IHC stain Result Pattern
AE1/AE3 Negative NA
GFAP Negative NA
S100 Focally positive Nuclear, mainly in hypocellular and hyaline areas




INI-1 Conserved Nuclear, all tumor cells
Ki-67 Low Nuclear, < 5% of tumor cells in hypocellular and moderate areas, and < 10% in hypercellular area.
IHC stain – immunohistochemical stain; NA – not applicable.
small, nodular, painless lesion with slow growth.1,6 A 
comprehensive review of the English-language literature 
identified only ten published cases of intraoral OFMT 
(Table 2). The real incidence of this lesion in the mouth 
may be underestimated, since proper diagnosis is 
difficult, considering the clinical, microscopical, and 
immunohistochemical features overlapping with 
several other lesions.
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A literature review on oral OFMT, including 
the current case, revealed a mean age of 31.6 years 
(ranging from 139,13 to 678 years), with a male: female 
ratio of 1.5:1. The most common clinical presentation 
was a painless nodule covered by normal mucosa and 
smooth surface. Three cases were described with a 
reddish surface.10-12 The tumor presented as slow-
growing, with a mean time of 6.9 months before 
diagnosis, except for one case that had a history of 
two weeks. This case was diagnosed as a malignant 
OFMT.12 The mean size of the lesions was 2.3 cm, 
ranging from 0.8 cm13 to 6.0 cm.11 These data were 
similar to extraoral cases of OFMT.1-3 Soft tissues 
of the mandible were the most commonly involved 
sites, including lower vestibule (3 cases), posterior 
lower gingiva (1 case), and retromolar trigone 
(1 case). However, it seems that any site of the oral 
mucosa can be affected, such as lip (2 cases), buccal 
mucosa (2 cases), soft palate (1 case), and dorsal 
tongue (1 case). Clinically, intraoral OFMT has several 
clinical differential diagnoses, including reactive and 
neoplastic lesions. Reactive lesions may include fibrous 
hyperplasia and deep mucocele. Among neoplastic 
lesions, mesenchymal and salivary gland tumors usually 
are considered in clinical differential diagnoses, such 
as lipoma14 and pleomorphic adenoma.15
OFMT is usually a well-circumscribed lesion with 
a partial or complete fibrous capsule that can produce 
fibrous septa. The main histopathological feature is the 
presence of a peripheral shell of lamellar bone within 
the fibrous capsule. Rarely, this bone may contain 
hematopoietic marrow,1,3 as observed in the current 
Figure 5. Immunohistochemical reactions of the intraoral ossifying fibromyxoid tumor. A – Ki67 was low (< 5%); 
B – however, in the hypercellular area had an increased rate (< 10%) (immunohistochemistry, 20x).
case. Some atypical OFMT cases may not present 
mature bone and osteoid,5 although all intraoral OFMT 
cases reported the presence of bone formation. In high 
cellularity areas, mild to severe atypia and mitoses can 
be found.1 Five OFMT cases of the oral cavity reported 
mitotic activity, and in one case, it was considered high 
in the recurrent lesion.12 Folpe and Weiss16 in 2003, 
proposed a risk stratification system for OFMT in which 
cases with a high nuclear grade, high cellularity and 
mitotic activity greater than 2 mitotic figures/50 HPF 
should be classified as “malignant OFMT”. Cases with 
atypical features, but not with all the criteria listed 
above, may be classified as “atypical OFMT” and 
considering the others as “typical OFMT”.2 Despite 
the presence of focal hypercellular areas, the mitotic 
activity was minimal. Hence, the current case was 
considered as a typical OFMT. Most of the reported 
intraoral cases were typical OFMTs, with only one 
exception, in which the recurrent tumor was classified 
as malignant OFMT.12
The immunohistochemical ( IHC) profile of 
intraoral OFMT is similar to cases arising in extraoral 
sites,3 with frequent positivity for vimentin (6/6), and 
S100 (4/6). Vimentin has been reported as being 
diffusely positive, while S100 expression was only 
focal, similar to the present case. GFAP and SMA 
showed focal immunoreactivity in one case each, 
but not in the present case. Other markers that can 
occasionally be expressed in extraoral OFMT cases 
(usually focally) are neurofilament, neuron-specific 
enolase (NSE), CD56, CD10, and MSA. Single case 
positivity for MSA and NSE was reported in intraoral 
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OFMT cases. Cytokeratins, AE1/AE3, desmin, CD34, 
calponin, p63, EMA, CD68, and CD99 were negative. 
Epithelial markers (cytokeratins, pan-cytokeratins, 
and EMA) have been described with focal and weak 
expression in cases with reduced expression of S100, 
particularly in malignant OFMT cases,2,3 however, 
a single case report of malignant OFMT in the oral 
cavity showed focal positivity for S100 and negativity 
for cytokeratins.12 The IHC profile was supportive 
of neuroectodermal differentiation of this lesion, 
although myoepithelial differentiation has also been 
suggested.2,6 However, in the broad profile of IHC of 
this lesion, it was difficult to determine the precise line 
of differentiation.
The range of differential histological diagnosis 
is broad, particularly in atypical cases of OFMT. It 
includes myxoid neurofibroma, peripheral nerve sheath 
tumor, low-grade fibromyxoid sarcoma, solitary fibrous 
tumor, ectomesenchymal chondromyxoid tumor (ECT), 
myoepitheliomal tumors, and glomus tumor (GT). 
Myoepithelioma is a salivary gland tumor formed by 
neoplastic myoepithelial cells that exhibit different cell 
shapes that varies from round to ovoid to fusiform 
surrounded by fibrous, hyaline, or fibromyxoid matrix. 
However, no chondroid or osseous metaplasia are 
found and myoepithelial markers, such as P63 and 
calponin, are positive.17 ECT also displays round to 
ovoid to fusiform cells with chondroid formation 
surrounded by fibromyxoid matrix, differing from 
OFMT in multilobulated aspect and absence of fibrous 
capsule and osteoid or bone formation.18 Furthermore, 
ECT affects almost exclusively the tongue and is positive 
for GFAP.18,19 GT is characterized by an encapsulated 
proliferation of epithelioid cells surrounded by 
numerous vessels with different sizes in a myxoid 
stroma. The neoplastic cells of GT are negative for 
S100.20 Additionally, all tumors mentioned above are 
not associated with the presence of a peripheral layer 
of lamellar bone.
Several studies have identif ied by IHC or 
fluorescence in situ hybridization (FISH) a mosaic 
pattern loss of INI-1 expression (integrase interactor 1/ 
SMARCB1/ hSNF5/ BAF47) in approximately 30 to 60% 
of neoplastic cells in up to three-quarters of extraoral 
OFMT cases.2,21 INI-1 is a tumor suppressor gene located 
on chromosome 22q11.2 that encodes a protein 
expressed essentially in all nucleated cells.22 The mosaic 
loss inactivation of this tumor suppressor gene in 
OFMT, including typical and malignant forms, has also 
been suggested as a role in tumorigenesis.2 However, 
INI-1 conserved expression has been identified in other 
studies, and the molecular mechanisms of this event in 
OFMT remain unclear.23 To the best of our knowledge, 
this is the first intraoral OFMT case reported in the 
English-literature that analyzed the immunoreactivity 
of INI-1. An intact nuclear expression was observed in 
all tumor cells.
OFMTs have been characterized as tumors with 
intermediate clinical behavior, although the majority 
behave in a benign manner. Some tumors present 
with local recurrence or rarely metastasizing to distant 
locations. Surgical excision is reported as the treatment 
of choice for OFMT.1,3 The majority of reported intraoral 
cases followed a benign course, with no evidence of 
recurrence or metastasis. Miettinen et al.1 reported 
that 22% of 104 cases had recurred, which usually 
manifested more than 10 years after the initial 
diagnosis, emphasizing that OFMT has a potential 
for late local recurrence, but no metastases were 
detectable in these cases. The locally recurrent tumors 
have been described with similar features as the 
nonrecurrent lesions, although some recurrent cases 
can exhibit increased cellularity and mitotic activity.24 An 
intraoral OFMT case reported by Ohta et al.12 recurred 
after 4 years of the primary diagnosis, presenting 
higher cellularity and mitotic activity, resulting in 
the recurrent tumor being diagnosed as a malignant 
OFMT. In a study conducted by Graham et al.,2 33% 
of patients diagnosed as malignant OFMT had adverse 
events, in which 2 patients had local recurrence, 3 had 
distant metastases, and 3 died from the disease. Finally, 
one intraoral case was reported as malignant OFMT, 
without evidence of metastatic tumor.12
CONCLUSION
In summary, OFMT is a soft tissue benign 
mesenchymal neoplasm with intermediate biologic 
behavior and rarely involves the oral cavity. Despite its 
usual benign clinical course, the correct diagnosis is 
important due to the risk of late local recurrence and 
eventual metastasis, although the latter not yet reported 
in intraoral cases. Thus, it is important to consider this 
lesion in both clinical and histopathological diagnosis 
of fibromyxoid soft neoplasms in the oral cavity and 
to have a long-term follow-up.
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